Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit α4

被引:90
作者
Liu, J
Prickett, TD
Elliott, E
Meroni, G
Brautigan, DL
机构
[1] Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA
[2] Telethon Inst Genet & Med, I-80131 Naples, Italy
关键词
D O I
10.1073/pnas.111154698
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Opitz syndrome (OS) is a human genetic disease characterized by deformities such as cleft palate that are attributable to defects in embryonic development at the midline. Gene mapping has identified OS mutations within a protein called Midi. Wild-type Midi predominantly colocalizes with microtubules, in contrast to mutant versions of Midi that appear clustered in the cytosol. Using yeast two-hybrid screening, we found that the alpha4-subunit of protein phosphatases 2A/4/6 binds Midi. Epitope-tagged alpha4 coimmunoprecipitated endogenous or coexpressed Midi from COS7 cells, and this required only the conserved C-terminal region of alpha4. Localization of Midi and alpha4 was influenced by one another in transiently transfected cells. Midi could recruit alpha4 onto microtubules, and high levels of alpha4 could displace Midi into the cytosol. Metabolic P-32 labeling of cells showed that Midi is a phosphoprotein, and coexpression of full-length a4 decreased Midi phosphorylation, indicative of a functional interaction. Association of green fluorescent protein-Midi with microtubules in living cells was perturbed by inhibitors of MAP kinase activation. The conclusion is that Midi association with microtubules, which seems important for normal midline development, is regulated by dynamic phosphorylation involving MAP kinase and protein phosphatase that is targeted specifically to Midi by alpha4. Human birth defects may result from environmental or genetic disruption of this regulatory cycle.
引用
收藏
页码:6650 / 6655
页数:6
相关论文
共 23 条
  • [1] The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors
    Beck, T
    Hall, MN
    [J]. NATURE, 1999, 402 (6762) : 689 - 692
  • [2] Inhibition of the Mr70,000 S6 kinase pathway by rapamycin results in chromosome malsegregation in yeast and mammalian cells
    Bonatti, S
    Simili, M
    Galli, A
    Bagnato, P
    Pigullo, S
    Schiestl, RH
    Abbondandolo, A
    [J]. CHROMOSOMA, 1998, 107 (6-7) : 498 - 506
  • [3] Functional characterization of the Opitz syndrome gene product (midin): evidence for homodimerization and association with microtubules throughout the cell cycle
    Cainarca, S
    Messali, S
    Ballabio, A
    Meroni, G
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (08) : 1387 - 1396
  • [4] α4 associates with protein phosphatases 2A, 4, and 6
    Chen, J
    Peterson, RT
    Schreiber, SL
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (03) : 827 - 832
  • [5] TOR signaling regulates microtubule structure and function
    Choi, JH
    Adames, NR
    Chan, TF
    Zeng, CB
    Cooper, JA
    Zheng, XFS
    [J]. CURRENT BIOLOGY, 2000, 10 (14) : 861 - 864
  • [6] Mutation of Tyr307 and Leu309 in the protein phosphatase 2A catalytic subunit favors association with the α4 subunit which promotes dephosphorylation of elongation factor-2
    Chung, HY
    Nairn, AC
    Murata, K
    Brautigan, DL
    [J]. BIOCHEMISTRY, 1999, 38 (32) : 10371 - 10376
  • [7] New mutations in MID1 provide support for loss of function as the cause of X-linked Opitz syndrome
    Cox, TC
    Allen, LR
    Cox, LL
    Hopwood, B
    Goodwin, B
    Haan, E
    Suthers, GK
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (17) : 2553 - 2562
  • [8] The mouse Mid1 gene:: implications for the pathogenesis of Opitz syndrome and the evolution of the mammalian pseudoautosomal region
    Dal Zotto, L
    Quaderi, NA
    Elliott, R
    Lingerfelter, PA
    Carrel, L
    Valsecchi, V
    Montini, E
    Yen, CH
    Chapman, V
    Kalcheva, I
    Arrigo, G
    Zuffardi, O
    Thomas, S
    Willard, HF
    Ballabio, A
    Disteche, CM
    Rugarli, EI
    [J]. HUMAN MOLECULAR GENETICS, 1998, 7 (03) : 489 - 499
  • [9] Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation
    Dennis, PB
    Fumagalli, S
    Thomas, G
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 1999, 9 (01) : 49 - 54
  • [10] Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases
    DiComo, CJ
    Arndt, KT
    [J]. GENES & DEVELOPMENT, 1996, 10 (15) : 1904 - 1916